The primary objective of this study was to systematically review and analyse epidemiological
studies of the prevalence and incidence of atopic dermatitis (AD) during childhood and …

Background Previous studies found conflicting results about the commonality of different
atopic dermatitis (AD) signs and symptoms. Objective To determine the prevalences of AD …

Background Previous studies found conflicting results about whether atopic dermatitis (AD)
begins in adulthood. Objective To determine rates, predictors, and phenotypic differences of …

Background Treatment of moderate‐to‐severe atopic dermatitis (AD) in the elderly may be
challenging, due to side‐effects of traditional anti‐inflammatory drugs and to comorbidities …

Atopic dermatitis (AD) is a heterogeneous disease with unique clinical manifestations across
age groups and race/ethnicities. Characteristic molecular mechanisms, known as …

Atopic dermatitis (AD) is a chronic, pruritic, inflammatory dermatosis that imposes significant
patient and population burdens. In addition to the cutaneous signs and symptoms, growing …

Atopic dermatitis (AD) is a chronic, lifelong, relapsing condition. The wide spectrum of the
possible clinical presentations, depending on patient's age, age of onset of disease …

Key research advances in atopic dermatitis (AD) suggest the complexity of its endotypes. A
comprehensive serum biomarker panel revealed at least 4 types of AD. Some represent …

Atopic dermatitis (AD) was once thought to be primarily a pediatric disease that remitted with
increasing age. However, recent epidemiologic studies showed that AD is a common and …

Recent epidemiological studies found the US prevalence of atopic dermatitis in adults to be
approximately 7%. In particular, one in four adults with atopic dermatitis report adult onset of …